MetLife Investment Management, LLC - AKCEA THERAPEUTICS INC ownership

AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 59 filers reported holding AKCEA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of AKCEA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$144,122
+43.0%
7,945
+8.0%
0.00%
+100.0%
Q2 2020$100,777
-4.2%
7,3560.0%0.00%0.0%
Q1 2020$105,191
-15.6%
7,3560.0%0.00%0.0%
Q4 2019$124,611
+10.1%
7,3560.0%0.00%0.0%
Q3 2019$113,209
-34.4%
7,3560.0%0.00%
-50.0%
Q2 2019$172,498
-17.2%
7,3560.0%0.00%0.0%
Q1 2019$208,395
-6.0%
7,3560.0%0.00%
-33.3%
Q4 2018$221,710
-13.9%
7,3560.0%0.00%0.0%
Q3 2018$257,607
+37.0%
7,3560.0%0.00%
+50.0%
Q1 2018$188,000
-5.5%
7,356
-35.8%
0.00%0.0%
Q4 2017$199,00011,4620.00%
Other shareholders

There were no reported owners of AKCEA THERAPEUTICS INC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of AKCEA THERAPEUTICS INC shareholders